2023 Twins of the Year

2023 Twins of the Year announced

The World Federation of Hemophilia (WFH) is pleased to announce the 2023 Twins of the Year! The 2023 Hemophilia Organization Twinning Program (HOT) Twins of the Year are Rwanda Fraternity Against Hemophilia (Rwanda) – Association Française des Hémophiles, Pays de la Loire (France). The 2023 Hemophilia Treatment Centre Twinning (HTC) Program Twins of the Year are Central General Hospital Dr. Kariadi Semarang (Indonesia) – Van Creveldkliniek Department of Benign Hematology University Medical Center Utrecht (Netherlands).

Also available in: Français Español

The WFH Twinning Program supports short-term collaborative partnerships between medical professionals, patient organizations, and youth leaders from around the world to improve care for people living with bleeding disorders worldwide. The 2023 Twins of the Year Awards were announced at the WFH 2024 World Congress in Madrid, Spain, where partners received recognition plaques in tandem with the 2022 Twins of the Year. At this event, past, current and new twins were celebrated and the WFH expressed its gratitude for Pfizer’s long-standing support of the WFH Twinning Program. The Program has had a significant global impact, with 275 partnerships created across 119 countries.

Serbia - Manitoba (Canada) 2023 Twins of the Year
Rwanda - France 2023 Twins of the Year
Dawn Rotellini, chair of the HOT Twinning Committee, presents the 2022 and 2023 HOT Twins of the Year awards to the Serbia – Manitoba (Canada) and the Rwanda – France twins (L to R).

The Rwanda-France twins had a productive and collaborative year. The twins conducted awareness-raising and capacity-building training for 60 community health workers, 104 parents, 150 teachers and 2,000 students. They engaged in productive dialogue with several institutions—such as the Ministry of Health and the Rwanda Biomedical Centre—to raise awareness and advocated for improved treatment and care for people living with bleeding disorders. They also built the Rwanda NMO website.

Amman (Jordan) - Dublin (Ireland) 2023 Twins of the Year
Semarang (Indonesia) - Utrecht (Netherlands) 2023 Twins of the Year
Catherine Lambert, chair of the HTC Twinning Committee, presents the 2022 and 2023 HTC Twins of the Year awards to the Amman (Jordan) – Dublin (Ireland) and the Semarang (Indonesia) – Utrecht (Netherlands) twins, respectively  (L to R).

In their third year, the Semarang – Utrecht twins maintained their momentum by enhancing awareness and knowledge among healthcare professionals on clinical management of bleeding disorders. They organized several activities to improve care for individuals living with bleeding disorders in Indonesia. These initiatives included developing a patient registry, creating personalized treatment plans, and establishing treatment protocols. Additionally, they conducted training sessions for physiotherapists and hosted two symposiums for medical and paramedical staff involved in hemophilia and other bleeding disorders care. Furthermore, the twins facilitated hydrotherapy sessions as part of their patient education programs.

On behalf of the WFH, congratulations to the 2023 Twins of the year!

For more information on the WFH Twinning Program, please click here.

The Twinning program is supported by exclusive funding from Pfizer.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.